Cargando…
MicroRNA Signature of Lung Adenocarcinoma with EGFR Exon 19 Deletion
The findings of EGFR mutations and the development of targeted therapies have significantly improved the overall survival of lung cancer patients. Still, the prognosis remains poor, so we need to know more about the genetic alterations in lung cancer. MicroRNAs are dysregulated in lung cancer, and s...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463447/ https://www.ncbi.nlm.nih.gov/pubmed/28607607 http://dx.doi.org/10.7150/jca.17817 |